1-3815431-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014704.4(CEP104):āc.2749A>Gā(p.Ser917Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000992 in 1,613,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Synonymous variant affecting the same amino acid position (i.e. S917S) has been classified as Likely benign.
Frequency
Consequence
NM_014704.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP104 | NM_014704.4 | c.2749A>G | p.Ser917Gly | missense_variant | 22/22 | ENST00000378230.8 | NP_055519.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP104 | ENST00000378230.8 | c.2749A>G | p.Ser917Gly | missense_variant | 22/22 | 5 | NM_014704.4 | ENSP00000367476.3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152234Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249552Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135052
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460776Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726606
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152234Hom.: 0 Cov.: 34 AF XY: 0.0000672 AC XY: 5AN XY: 74372
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2023 | The c.2749A>G (p.S917G) alteration is located in exon 22 (coding exon 21) of the CEP104 gene. This alteration results from a A to G substitution at nucleotide position 2749, causing the serine (S) at amino acid position 917 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at